Literature DB >> 9445117

The relative safety of MRI contrast agent in acute necrotizing pancreatitis.

J Werner1, J Schmidt, A L Warshaw, M M Gebhard, C Herfarth, E Klar.   

Abstract

OBJECTIVE: To validate the safety of gadolinium-diethylenetriamine pentaacetic acid (GD-DTPA) by measuring its effect on pancreatic capillary perfusion and acinar injury in acute pancreatitis.
BACKGROUND: Contrast-enhanced computed tomography (CECT) is proposed as a gold standard for early evaluation of acute necrotizing pancreatitis. However, iodinated contrast media used for CECT have been shown in these circumstances to reduce pancreatic capillary flow and increase necrosis and mortality. Recent reports suggest that post-GD MRI provides images comparable to CECT in the assessment of severe acute pancreatitis.
METHODS: Necrotizing pancreatitis was induced in 14 Wistar rats by intraductal glycodeoxycholic acid (10 mM/L) and intravenous caerulein (5 microg/kg/h) over 6 hours. Intravital microscopic quantitation of pancreatic capillary blood flow was performed using fluorescein isothiocyanate-labeled erythrocytes after induction of pancreatitis and 30 and 60 minutes after an intravenous bolus of either Ringer's solution or GD-DTPA (0.2 mL/kg).
RESULTS: The two study groups were comparable with regard to mean arterial pressure, heart rate, arterial blood gases, hematocrit, amylase, lipase, and trypsinogen activation peptide production throughout the experiment. GD-DTPA did not reduce capillary flow (1.93 +/- 0.05 nL/capillary/min) compared to animals infused with Ringer's solution (1.90 +/- 0.06 nL/capillary/min).
CONCLUSIONS: Intravenous injection of GD-DTPA does not further impair pancreatic microcirculation or increase acinar injury in acute necrotizing pancreatitis. Because of this advantage over CT contrast medium, further development of MRI as a staging tool in acute pancreatitis seems desirable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445117      PMCID: PMC1191179          DOI: 10.1097/00000658-199801000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  48 in total

1.  Pancreatic disease: findings on state-of-the-art MR images.

Authors:  D G Mitchell; M Shapiro; A Schuricht; D Barbot; F Rosato
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

2.  Peritoneal dialysis in the treatment of acute alcoholic pancreatitis.

Authors:  H H Stone; T C Fabian
Journal:  Surg Gynecol Obstet       Date:  1980-06

3.  Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. II. The complement system and endothelial cells.

Authors:  M Akagi; S Masaki; K Kitazumi; M Mio; K Tasaka
Journal:  Methods Find Exp Clin Pharmacol       Date:  1991-09

Review 4.  Imaging and intervention in acute pancreatitis.

Authors:  E J Balthazar; P C Freeny; E vanSonnenberg
Journal:  Radiology       Date:  1994-11       Impact factor: 11.105

5.  Intravenous contrast medium impairs oxygenation of the pancreas in acute necrotizing pancreatitis in the rat.

Authors:  T Foitzik; D G Bassi; C Fernández-del Castillo; A L Warshaw; D W Rattner
Journal:  Arch Surg       Date:  1994-07

6.  Magnetic resonance and CT of the normal and diseased pancreas: a comparative study.

Authors:  D D Stark; A A Moss; H I Goldberg; P L Davis; M P Federle
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

7.  Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor.

Authors:  C Niederau; R A Crass; G Silver; L D Ferrell; J H Grendell
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

8.  Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates.

Authors:  J Schmidt; C Fernández-del Castillo; D W Rattner; K Lewandrowski; C C Compton; A L Warshaw
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

9.  Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.

Authors:  J Norman; M Franz; J Messina; A Riker; P J Fabri; A S Rosemurgy; W R Gower
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

10.  Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP).

Authors:  P R Hurley; A Cook; A Jehanli; B M Austen; J Hermon-Taylor
Journal:  J Immunol Methods       Date:  1988-07-22       Impact factor: 2.303

View more
  2 in total

Review 1.  Contrast-enhanced computed tomography in acute pancreatitis: does contrast medium worsen its course due to impaired microcirculation?

Authors:  Jan A Plock; Joachim Schmidt; Suzanne E Anderson; Michael G Sarr; Antoine Roggo
Journal:  Langenbecks Arch Surg       Date:  2005-02-12       Impact factor: 3.445

2.  On the protective mechanisms of nitric oxide in acute pancreatitis.

Authors:  J Werner; C Fernández-del Castillo; J A Rivera; N Kollias; K B Lewandrowski; D W Rattner; A L Warshaw
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.